[At what age should oral contraception be stopped?]. / A quel âge faut-il arrêter la contraception orale?

The "pill" is generally considered inadvisable after the age of 40, chiefly because of vascular risk. The authors thus raise the question of possible continued oral contraception until the menopause using new estroprogestational agents. They discuss in turn the usefulness of contraception after the age of 40, bearing in mind the significant fall in fertility at this age and the vascular, gynecological and breast risks linked to oral contraception. It emerges, on the basis of data from the literature, that estroprogestational agents can be continued until the menopause, and in particular since they are associated with beneficial effects: protective role against carcinoma of the ovary and endometrium, comfort associated with use of the pill in terms of regular cycle but also the prevention of early estrogen deficiency and osteoporosis in particular, all the more so since a pregnancy after the age of 40 is a far greater risk than that linked to the use of a current oral contraceptive, obviously after patients with a known risk factor have been eliminated.

[Changing management of breech presentation in a primipara]. / Evolution de la conduite à tenir en présentation du siège chez la primipare.

The authors investigate the changing management based on a score including the prognostic items in a primiparous woman with a breach presentation. The study involved two series: one from 1970 to 1975, including 185 breach position primiparous women before the score was established, and the other, dating from 1982 to 1988, consisting of 145 breach position primiparous women after this score came into use. The use of the score has tripled the number of cesareans but reduced neonatal morbidity. In contrast, the authors note a slight increase in maternal morbidity, related to the increased cesarean rate.